Who do we work for?
CDMO
CEO or CFO
“I do not want to fill up all my valuable capacity with molecules that are unlikely to succeed“
Our first tool, the P2MT, was developed for a mid-sized CDMO, backed by private equity. The questions centred on portfolio valuation in 5 years time, degree of risk and how realistic is the current plan.
Mid Size CDMO
Head of Business Development
“My BD team generated 400 leads at CPHI – but which are valuable? “
Once your portfolio reaches more than 50 molecules, you need to start being more selective about which business you take on. Get a realistic view of your leads. Price effectively. Allocate BD resources efficiently. Know which molecules will best fit with your equipment. Set up template for each set of capabiliies that you offer. Use the Evaluator tool
Small Size CDMO
Head of Business Development
“We just need to fill up the pipeline. portfolio management comes later”
We know what it is like to be a small company with a limited budget. Use our Fractional Business Development Service. We start with a discussion about what your goals are. We know that you need 40 relevant leads, not a list of 4,000 potentials. We work with you to identify the right contacts, tell a compelling story
Business Development Intensification
Network Planner
“How are we going to fill up all this new capacity?“
You are planning capacity expansion but how many contracts will you need to fill up the new capacity? Model different mid-long range plans. Our portfolio tool allows you to project volume and value out for 5 or 10 years. Take into account the likelihood of success.
Private Equity Owner of CDMO
“I need a realistic overview of the value of the sales pipeline – because we are looking to exit “
Sales & BD teams are paid to be optimistic. But you need to know what is the realistic value of the portfolio. Use our risk-adjusted values and volumes to see how the portfolio will develop in the next few years
Chief Scientific Officer
“I need to be able to speak Finance to the CEO and CFO….but still manage technical risk“
You have an ever-changing portfolio of projects. With a wide range of molecules having different risk profiles, you need to be able to model changes quickly. Use our Portfolio Tool And then speak the language of finance to the CEO and CFO, all the while managing scientific risk.